Is an Alternative Drug Delivery System Needed for Docetaxel? The Role of Controlling Epimerization in Formulations and Beyond

Author： Manjappa Arehalli   Goel Peeyush   Vekataraju Makam   Rajesh Kesarla   Makwana Kinjal   Ukawala Mukesh   Nikam Yuvraj   Gude Rajiv   Murthy Rayasa  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.30, Iss.10, 2013-10, pp. : 2675-2693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System

By  

Current Drug Targets, Vol. 16, Iss. 14, 2015-12 ,pp. : 1645-5

Bentham Science Publishers

Access to resources Recommend Favorite

Controlling drug delivery across the placenta

By Audus K.L.  

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 3, 1999-07 ,pp. : 161-165

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery

By  

Pharmaceutical Nanotechnology, Vol. 5, Iss. 1, 2017-03 ,pp. : 3-23

Bentham Science Publishers

Access to resources Recommend Favorite

The role of the transferrin-transferrin-receptor system in drug delivery and targeting

By Li H.   Sun H.   Qian Z.M.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 5, 2002-05 ,pp. : 206-209

Elsevier

Access to resources Recommend Favorite

Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

By Fricker Gert   Kromp Torsten   Wendel Armin   Blume Alfred   Zirkel Jürgen   Rebmann Herbert   Setzer Constanze   Quinkert Ralf-Olaf   Martin Frank   Müller-Goymann Christel  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1469-1486

Springer Publishing Company

Access to resources Recommend Favorite